Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
3.600
+0.050 (1.41%)
At close: Mar 13, 2026, 4:00 PM EDT
3.470
-0.130 (-3.61%)
After-hours: Mar 13, 2026, 4:22 PM EDT

Alterity Therapeutics Revenue

Alterity Therapeutics had revenue of 2.80M AUD in the half year ending December 31, 2025, with 47.49% growth. This brings the company's revenue in the last twelve months to 6.64M, up 78.18% year-over-year. In the fiscal year ending June 30, 2025, Alterity Therapeutics had annual revenue of 5.44M with 35.32% growth.

Revenue (ttm)
6.64M AUD
Revenue Growth
+78.18%
P/S Ratio
14.74
Revenue / Employee
737,380 AUD
Employees
9
Market Cap
65.25M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20255.44M1.42M35.32%
Jun 30, 20244.02M102.95K2.63%
Jun 30, 20233.92M-1.21M-23.56%
Jun 30, 20225.12M783.93K18.06%
Jun 30, 20214.34M--
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro